Sarissa Capital Management LP Portfolio Holdings
Sarissa Capital Management LP
- $134 Million
- Q2 2025
Sarissa Capital Management LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $134 Million distributed in 7 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Innoviva, Inc. with a value of $56.6M, Neurocrine Biosciences Inc with a value of $38.1M, Cytokinetics Inc with a value of $19.4M, Ironwood Pharmaceuticals Inc with a value of $11.5M, and Lantheus Holdings, Inc. with a value of $7.88M.
Examining the 13F form we can see an decrease of $232M in the current position value, from $366M to 134M.
Sarissa Capital Management LP is based out at Greenwich, CT
Below you can find more details about Sarissa Capital Management LP portfolio as well as his latest detailed transactions.